VOLITIONRX LTD — Director's Dealing 2022

Sep 20, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2022-09-19-05:00

Reporting Person: Micallef Jacob Vincent (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-09-19-05:00	Common Stock	P	13000	$1.70	Acquired	35000	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	149228	Direct
Common Stock	38113	Indirect

Footnotes

F1: The shares of common stock are held directly by Borlaug Limited. The reporting person is a controlling director of Borlaug Limited and has voting and dispositive control over the shares of common stock held by Borlaug Limited.